Ceribell wins CMS NTAP for delirium monitor, worth up to $2,171 per Medicare casePUBT·1 day ago, 06:03 AMCBLL+1.15%
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor SystemUnusual Whales·1 day ago, 06:03 AMCBLL+1.15%
CeriBell (CBLL) Expected to Announce Quarterly Earnings on MondayMarket Beat·2 days ago, 02:56 AMCBLL+1.15%TPG+5.74%
Ceribell files Form 3 initial beneficial ownership statement for director Sharon O’KeefePUBT·Jul 30 at 06:39 PMCBLL+1.15%
Ceribell CFO to join Canaccord Genuity Growth Conference fireside chatPUBT·Jul 28 at 03:13 PMCBLL+1.15%
Insider Selling: CeriBell (NASDAQ:CBLL) CEO Sells $776,100.00 in StockMarket Beat·Jul 9 at 12:07 PMCBLL+1.15%JPM+1.38%
Ceribell CEO Xingjuan Chao sells 39,000 common shares for USD 776,100PUBT·Jul 9 at 11:35 AMCBLL+1.15%
Ceribell director William W. Burke sells 2,207 common shares for $43,786.88PUBT·Jul 2 at 11:09 AMCBLL+1.15%
Bank of America Securities Remains a Buy on Ceribell, Inc. (CBLL)Tip Ranks·May 17 at 08:25 AMCBLL+1.15%
CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit RecordsMarket Beat·May 15 at 12:07 AMCBLL+1.15%
